🔎 Trials Near Me

መነሻ › የሳንባ መካከለኛ ሕዋስ በሽታዎች › ካሊፎርኒያ › Los Angeles

በLos Angeles፣ CA ለየሳንባ መካከለኛ ሕዋስ በሽታዎች የሚደረጉ ክሊኒካዊ ጥናቶች

ለየሳንባ መካከለኛ ሕዋስ በሽታዎች የሚደረጉ 14 ጥናቶች በLos Angeles እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Southern California, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of California Los Angeles, Los Angeles
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • USA010, Los Angeles
  • USA023, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07179380

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06716606

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Southern California, Los Angeles
  • Cedars Sinai Medical Center, Los Angeles
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06968845

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • David Geffen School of Medicine at UCLA, Los Angeles
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Cedars-Sinai Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Keck School of Medicine at USC Medical Center, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of California - Los Angeles, Los Angeles
  • University of Southern California, Los Angeles
እድሜ 21 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Peter Morton Medical Building, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT05943535

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Keck School of Medicine of USC, Los Angeles
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኖቬም 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • aTyr Investigative Site, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ሜይ 2025 · NCT05892614

በሌሎች ከተሞች ለየሳንባ መካከለኛ ሕዋስ በሽታዎች የሚደረጉ ጥናቶች

በLos Angeles ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።